Body composition and mortality in chronic obstructive pulmonary disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 1 of the 47 sources its claims cite were checked for support.
Overview
CoChat Summary
TL;DR
In 412 patients with moderate-to-severe COPD, fat-free mass index independently predicted all-cause mortality, whereas fat mass index did not. Low fat-free mass categories (cachexia and muscle atrophy) had worse survival than no impairment, supporting body-composition assessment as a systemic marker in COPD staging.
Key findings
- During a maximum follow-up of 5 y (mean 48 ± 20 mo), 46% of patients (n = 189) died.
- After adjustment for age, sex, FEV₁, IVC, PaCO₂, and PaO₂, fat-free mass index was an independent predictor of mortality (RR: 0.90; 95% CI: 0.84, 0.96; P = 0.003), but fat mass index was not (RR: 1.02; 95% CI: 0.95, 1.09; P = 0.680).
- Median survival was significantly worse in cachexia (26 mo; 95% CI: 21, 31 mo) and muscle atrophy (24 mo; 95% CI: 15, 33 mo) than in semistarvation (36 mo; 95% CI: 28, 44 mo) or no impairment (47 mo; 95% CI: 37, 57 mo) (P < 0.001).
- Cachexia was significantly more prevalent in GOLD stage IV than in GOLD stages II and III (P = 0.001); by SMI criteria, 51% of the total population was at moderate and 31% at high risk of physical disability.
Methods
- Cohort study of 412 clinically stable COPD patients (GOLD stages II–IV; FEV₁ 36 ± 14% of predicted, range 19–70%) screened for admission to a clinical pulmonary rehabilitation program between 1 January 1988 and 30 December 1991; mortality was assessed on 31 January 1993, with follow-up of 2–5 y or until death.
- Body composition was assessed by single-frequency bioelectrical impedance (50 Hz); fat-free mass was calculated with disease-specific equations, fat mass as body weight minus fat-free mass, and FFMI, FMI, and SMI were calculated and compared with reference values. Patients were stratified into cachexia, semistarvation, muscle atrophy, or no impairment by BMI and FFMI cutoffs.
- Main analysis used Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards models, unadjusted and adjusted for age, sex, disease severity (FEV₁, IVC, PaO₂, PaCO₂), and GOLD classification; P < 0.05 was considered significant.
Limitations
- Stated in the paper: the study population was skewed toward more males and more severe GOLD stages III and IV, and the semistarvation and muscle atrophy categories were relatively small.
- Stated in the paper: smoking status was not objectively verified (e.g., by cotinine measurements), and because smoking was not associated with mortality in these subjects, the reported models excluded smoking.
- Evident from the text: body composition was measured only at baseline, so the sequence of body-composition changes could not be established; emphysema severity was not adjusted for despite being discussed as potentially relevant; and the cohort was selected from rehabilitation screening in the southern Netherlands, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 36 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“These studies all indicate that BIA may be a useful clinical screening instrument for characterization of the tissue-depletion pattern in chronic lung disease.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
What the sources say
- Not checked yetcites [12] Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465-71. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [19] Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skel- etal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21. source
Checked before — its earlier verdict is held back until a new check runs.
- Could not verifycites [20] Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-9. sourceExperimental — accuracy not yet measured
Our copy of Gosker et al. (2002) only uses BIA as one of two ways to determine fat-free mass (Methods, 'Assessment of body composition': single-frequency 50 kHz BIA with the disease-specific equation of Schols et al, ref 13) and reports that FFM_BIA correlated with total mean fiber cross-sectional area in the COPD patients (Results/'3-5' passage and Figure 3, r = 0.87, P < 0.001). No passage in our copy evaluates or states that BIA is a useful clinical screening instrument, nor does it use the notion of a 'tissue-depletion pattern' or generalize beyond its 15 stable COPD patients versus 15 controls (Study population). Searched: 'bioelectrical impedance analysis useful clinical screening instrument tissue depletion chronic lung disease', 'FFM BIA validity comparison DXA', 'screening instrument tissue depletion pattern chronic lung disease', 'discussion BIA fat-free mass muscle mass loss wasting clinical implications' — none returned a statement on BIA's screening utility. The validating comparison of BIA with deuterium dilution is credited elsewhere in the reference list (Schols et al. 1991, ref 13), but our copy does not attribute the screening-instrument conclusion to it, so this is not misattribution on our evidence. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cachexia was significantly (P ҃ 0.001) more prevalent in GOLD stage IV than in GOLD stages II and III.”
- Also stated in: § Abstract · plain
“Semistarvation and muscle atrophy were equally distributed among disease stages, but the highest prevalence of cachexia was seen in GOLD stage IV.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an associationn = 412- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
None of the sources cited for this claim have been checked yet.
In the paper
“In line with that study, male patients in the current study were at higher risk of physical disability than were female patients.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Univariate analysis showed that low BMI, FFMI, and FMI were significantly associated with increased mortality risk (Table 3).”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forty-six percent of the patients (n ҃ 189) died during a maximum follow-up of 5 y.”
- Also stated in: § 6 x Ȁ SD (all such values). · plain
“The mean duration of follow-up was 48 Ȁ 20 mo, during which time 46% of the patients died.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > Abstract
plainn = 189- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 6 x Ȁ SD (all such values). · plain
32 more claims
Create a free account to see all 63 claims and to verify the 42 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.23”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.68, 2.24; NS”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“Mean FFMI in categories 2 and 4 was within median range (50th percentile) except for male patients in category 2, whose values were below the 10th percentile.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“4: No impairment (n ҃ 55) | 59 | 17.6 Ȁ 2.2 | 90th”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“physical disability risk was clearly lower in categories 3 and 4”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“significantly (P 0.001) more patients were at moderate to high risk of disability in the cachexia and muscle atrophy categories (ie, 1 and 3) than in semistarvation and noimpairment categories (ie, 2 and 4)”
Citations
Cites
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 1×
“On the basis of numerous reports showing an association between BMI and mortality risk in COPD, Celli at al (26) recently proposed that clinical staging for COPD should be based not only on spirometry and resting arterial blood gases, eg, the recent GOLD criteria, but also on BMI, exercise capacity, and dyspnea score.”
BackgroundAssessment of fat-free mass using bioelectrical impedance measurements of the human body
Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896 · cited 1×
“Bioelectrical impedance analysis (BIA) is an easy, safe, noninvasive, and convenient method of measuring the lean and fat body compartments (11).”
MethodEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Self-citationPrognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
LANDBO, C., PRESCOTT, E., LANGE, P., VESTBO, J., & ALMDAL, T. P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9902115 · Cited by 1,033
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Self-citationFat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J., & Wouters, E. F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551381 · Cited by 463
Self-citation
Cited by
Items 801–898 of 898
de Moraes, L. R., Duarte, A. A. M., Reinaldo, G. P., Lago, P. D., & de Araújo, C. L. P. (2021) · ASSOBRAFIR Ciência · doi:10.47066/21779333.ac.2020.0034
To be malnourished or not to be malnourished: that is the question!
Jouneau, S., Kerjouan, M., & Thibault, R. (2021) · European Respiratory Journal · doi:10.1183/13993003.02455-2021
The clinical effects of specific exercise interventions in CHF and COPD patients
Wright, P. R. (2013) · Qucosa (Saxon State and University Library Dresden)
Obesity and Chronic Obstructive Pulmonary Disease
Franssen, F. M. E., & Wouters, E. F. �. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-053-3_8
Self-citationVoeding bij chronische longziekten
Rutten, E. P. A., & Schols, A. M. W. J. (2013) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0508-7_75
Self-citationO’Brien, E., Sciurba, F. C., & Bon, J. M. (2020) · Respiratory medicine · doi:10.1007/978-3-030-31507-8_15
Breyer, M. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131003mb
Intercepting Smoking-Related Respiratory Disease
Bailey, J. I., & Kalhan, R. (2022) · CHEST Journal · doi:10.1016/j.chest.2021.12.637
Função e massa muscular em pacientes com doença pulmonar obstrutiva crônica
Sanchez, F. F. (2007) · Americanae (AECID Library)
Nutrition and Acute Lung Injury in Critical Care: Focus on the Nutrition Care Process
Hanson, C., Rutten, E. P. A., Rollins, C., & Dobak, S. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8503-2_34-1
Associations between serum mitokine levels and outcomes in stable COPDPreprint
Diago, C. A. A., Martín-Audera, P., Calvo, J. A., Lavín, B. A., Guerra, R. A., Muñoz, P., Berja, A., Casanova, C., & García-Unzueta, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1647354/v1
Associations between serum mitokine levels and outcomes in stable COPDPreprint
Diago, C. A. A., Martín-Audera, P., Calvo, J. A., Lavín, B. A., Guerra, R. A., Muñoz, P., Berja, A., Casanova, C., & García‐Unzueta, M. T. (2022) · Research Square · doi:10.21203/rs.3.rs-1647354/v2
Body Mass as a Biomarker and Femoral Fracture
Nishioka, S., Inoue, T., & Onizuka, S. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-87302-8_57-1
Kentson, M. U. (2022) · Linköping University medical dissertations · doi:10.3384/9789179294526
Lung cancer cachexia: decoding molecular mechanisms and imaging the dynamics of muscle wasting
van de Worp, W. R. P. H. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20221214ww
Body Mass as a Biomarker and Femoral Fracture
Nishioka, S., Inoue, T., & Onizuka, S. (2023) · Biomarkers in disease · doi:10.1007/978-3-031-07395-3_57
Djajalaksana, S., Muktiati Nunuk, S., Sartono, T. R., Iriani, V., Renata, R., Adhi, S., & Rasyid, H. A. (2023) · Russian Open Medical Journal · doi:10.15275/rusomj.2023.0202
Nutritional Deficiencies in Patients with Chronic Obstructive Pulmonary Disease
TAGUCHI, S. (2023) · Rigakuryoho Kagaku · doi:10.1589/rika.38.313
Singh, K., Agrawal, A., Kharb, S., & Kaur, J. (2023) · The Indian Journal of Chest Diseases and Allied Sciences · doi:10.5005/jp-journals-11007-0073
Profile of malnourished COPD patients: A comparative study
Djebaili, R., Righi, N., & Chiboub, B. (2024) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2024.11.1.0177
Suporte nutricional na doença pulmonar obstrutiva crônica
Martins, G. A. R., & Rocco, P. R. M. (2023) · Anais da Academia Nacional de Medicina · doi:10.52130/27639878-aanm2023v194n1p66-80
Alteración del estado de nutricional en pacientes con enfermedad obstructiva crónica (EPOC)
Peñafiel-Erazo, D. S., & Melo, V. C. J. (2024) · MQRInvestigar · doi:10.56048/mqr20225.8.1.2024.5732-5752
α-1 Antitripsin Eksikliğinde Epigenetik ve Beslenme
Özçalkap, R., & Büyükuslu, N. (2024) · İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi · doi:10.38079/igusabder.1340587
Future Research Questions for Improving COPD Diagnosis and Care
Sadaka, A. S. (2024) · Frontiers research topics · doi:10.3389/978-2-8325-4890-5
Relationship between Sarcopenia and Respiratory Functions in Geriatric Male COPD Patients
Kara, K., Önür, S. T., Akyıl, F. T., Abalı, H., & Sökücü, S. N. (2024) · Istanbul Medical Journal · doi:10.4274/imj.galenos.2024.82520
Adetiloye, A. O., Akor, A. A., Awopeju, O., Adewole, O., Badero, O. J., & Erhabor, G. E. (2024) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol09-i07/1921
Prediction of spirometry outcome in Croatian patients with chronic obstructive pulmonary disease
Bešić, E., Muršić, D., Glunčić, T. J., Ostojić, J., Škrinjarić-Cincar, S., Dokoza, M., Lazarušić, N. K., Samaržija, M., & Dugac, A. V. (2024) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2024.3099
Obesity in COPD: Further exploring the complex interaction
Zewari, S. (2025) · Radboud University Press eBooks · doi:10.54195/9789465150246
Geriatriklerde Egzersiz Reçetesi
ŞENLİK, M. K. (2024) · Bidge Yayınları eBooks · doi:10.70269/10.70269/2345973125
The Significance of Assessing Quadriceps Contractile Index in COPD Patients
Meridj, A., Belala, R., & Djeghri, Y. (2025) · Series of clinical and biomedical research. · doi:10.54178/2997-2701.v2i1a2003
Ballemans, J., Geerars, M., Shoughiniya, H., van Loon, A. M., & Smit, E. B. (2025) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2025.2571576
Cheng, C., Wang, X., Huang, M., He, J., Li, M., & Cui, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-7413461/v1
Hasan, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-7810-5_34
Epidemiological Profile and Clinical Spectrum of COPD Patients in a Tertiary Care Hospital
Gordhanbhai, K. H., Ashvinbhai, K. A., & Rasikbhai, K. S. (2025) · International Journal of Pharmaceutical Quality Assurance · doi:10.25258/ijpqa.16.9.41
Distinct Myogenic Stages Recapitulate Transcriptomic Networks of Skeletal Muscle in COPD CachexiaPreprint
Sothers, H., Lukusa-Sawalena, B. K., Lavin, K. M., Ma, W., Chiles, J. W., Casaburi, R. H., Patel, R. P., Wells, J. M., Kazamel, M., Rossiter, H. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.03.692216
Hallin, R. (2009) · Uppsala University Publications (Uppsala University)
Siafaka, M. (2020) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.10925
慢性気道疾患の臨床経過・予後に対する経年変化データの影響に関する研究
阿部, 結. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.14943/doctoral.k14927
Chen, W., Sadatsafavi, M., FitzGerald, J. M., Lynd, L. D., & Sin, D. D. (2021) · Figshare · doi:10.6084/m9.figshare.14059450
Die Praktikabilität des BODE-Index bei schwer exazerbierten COPD-Patienten
Colsman, M. F., & Justus Liebig University Giessen (2011) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-13670
Zou, R. H., Nouraie, S. M., Karoleski, C. M., Zhang, Y., Sciurba, F. C., Forman, D. E., & Bon, J. (2024) · Figshare · doi:10.6084/m9.figshare.26619049
O músculo esquelético periférico no atingimento sistémico da DPOC
Ornelas, M. F. G. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/b6m2-zt86
Depleção de massa livre de gordura em DPOC e sua relação com manifestações extrapulmonares da doença
da Costa, A. C. T. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Системне запалення, як предиктор перебігу захворювання у пацієнтів з ХОЗЛ
Коритова, К. П. (2017) · Electronic Sumy State University Institutional Repository (Sumy State University)
Sábio, L. R. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Avaliação nutricional de pacientes com hipertensão pulmonar e sua relação com desempenho funcional
Zanella, P. B. (2016) · Americanae (AECID Library)
Ünlü, B. (2019) · Dspace Repository (Marmara Üniversitesi)
Nutritional Status and Dietary intake in patients with Non Cystic Fibrosis Bronchiectasis
King, L. (2024) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Schneider, L. P. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Sustaita Soto, N., & Arciniega, A. D. B. (2014) · Institutional Repository (Universidad Autónoma del Estado de México)
Martín-Audera, P. (2023) · UCrea (University of Cantabria)
THE EFFECT OF BODY MASS INDEX ON PHYSICAL FUNCTION IN PATIENTS WITH COPD
Michalak, E. D. (2020) · WakeSpace Scholarship (Wake Forest University)
Ernæringsscreening av lungepasienter. Plan for innføring av screeningverktøy ved lungeavdeling
Høvding, B. O., Vassbotn, A. D., Løvhaug, C., Vintermyr, H., Bruheim, M. J., Phatak, R. A., & Amundsen, V. S. (2019) · NORA - Norwegian Open Research Archives
Altération de la régénération musculaire dans la maladie pulmonaire obstructive chronique
Thériault, M.-E. (2016)
Hernández Núñez, M. G., Varela‐Moreiras, G., García, L. C., & Rubio Herrera, M. Á. D. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Love, N. J. (2016) · WakeSpace Scholarship (Wake Forest University)
이인선 (2013) · YUHSpace (Yonsei University Medical Library)
Fully Automated Medical Image Analysis Facilitating Subsequent User Analysis
Andrews, S. D. (2014) · Summit (Simon Fraser University)
CORRELATION BETWEEN BODY MASS INDEX AND FEV1 IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Jalal, M., Ahmad, H., Khan, A. A., Rahman, A., Shah, S. A., & Sundas, A. (2025) · The Research of Medical Science Review · doi:10.5281/zenodo.16939802
Saxena, A., Pathak, R., Diwakar, P., Srivastava, A., Chaudhary, V., Tripathi, S., & Kamal, D. (2025) · Acta Medica International · doi:10.21276/amit.2025.v12.i3.49
Martins, D. G. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Efectos fisiológicos del ejercicio en adultos mayores con y sin discapacidad intelectual
Aguilar, E. E. R., Bermúdez, L. M. V., & Altamiranda‐Saavedra, M. (2020) · Repositorio Institucional POLIJIC
Is fat free mass or fat mass capable of reflecting sedentary time in individuals with COPD?
Nobile, F. D., Tofoli, T. M., Santin, L., Medeiros, L. D. A., Krokoch, H., & Pitta, F. D. O. (2026) · Brazilian Journal of Respiratory Cardiovascular and Critical Care Physiotherapy · doi:10.47066/2966-4837.e00562025en
Contribution à la caractérisation des maladies respiratoires chroniques obstructives au Vietnam
Nguyen, T. C. (2025) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
C.O.P.D is a Systematic Inflammation Disease
Spyropoulou, G., Spiropoulou, A.-P., Vasileios Spyropoulos, M. S., & Spiropoulos, K. V. (2026) · Archives of Pulmonology and Respiratory Medicine · doi:10.22259/2639-362x.0901002
Supplémentation en DHA et muscle squelettique de rat adulte en hypoxie
Guen, M. L. (2013) · theses.fr (ABES) · doi:10.70675/e8a7238dz23a3z4701zbce9z3c655b271719
Lien entre muscle et microbiote intestinal dans la cachexie cancereuse
Simonson, M. (2024) · theses.fr (ABES) · doi:10.70675/7cd50e31z01f8z40f3z953az7777c5c68fac
Posthuma, R. (2026) · Research Publications (Maastricht University) · doi:10.26481/dis.20260402rp
Wang, Z., Xu, W., Xuan, Y., Shen, M., Wang, C., Sun, J., & Wang, H. B. (2026) · Research Square · doi:10.21203/rs.3.rs-9058704/v1
Yılmaz, A. İ., Pekcan, S., Eyüboğlu, T. Ş., Cüceoğlu, M. K., Kahraman, A. B., Bağcı, Z., Güzel, S. M., Ercan, F., Çağlar, H. T., Ayman, F. N., et al. (2026) · Klinische Pädiatrie · doi:10.1055/a-2875-4698
がん患者の悪液質発症を予測するための自律神経機能評価の有用性の検討 : がん理学療法分野における新たな評価指標の開発
TAKAHASHI, D., & 高橋, 大. (2017) · Institutional Repositories DataBase (IRDB)
Hiramoto, T., Izuno, S., Toda, K., Moriwaki, A., & Yoshida, M. (2026) · BioPsychoSocial Medicine · doi:10.1186/s13030-026-00364-0
vieira, J. D. M., & da Silva, R. M. (2026) · Respiratory Research & Clinical Practice · doi:10.36416/1806-3756/e20260125
Briki, C., Kchaou, K., Maalej, M., Bouslama, S., Khaldi, S., & Jameleddine, S. B. K. (2026) · Respiratory Care · doi:10.1177/19433654261459030
Khosroshahi, R. A., Mahmoodi, S., Zamanian, N., Talebi, S., Barkhordar, M., Sadeghi, E., & Mohammadi, H. (2026) · Nutrition and Cancer · doi:10.1080/01635581.2026.2710446
Srigiripura, C. V., Chaya, S. K., Siddaiah, J. B., Anand, M. P., & Urooj, A. (2026) · PULMON · doi:10.4103/pulmon.pulmon_3_26
Bagul, R., Kshirsagar, R., Koli, D., Arun, N., Bacche, J., Utpat, K. V., & Desai, U. D. (2026) · Journal of Advanced Lung Health · doi:10.4103/jalh.jalh_17_26
Bujeda, Á. B., Großmann, K., Spielmanns, S., Heeb, P., Lale, N., Prins, D., Bachmann, S., & Spielmanns, M. (2026) · Respiration · doi:10.1159/res/aepag017
Catană, O. M., Mitroi, D. M., Cioboată, R., Zlatian, O. M., Popescu-Drigă, M. V., Călăraşu, C., & Streba, C. T. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1915198
Study of body composition and systemic effects in Chronic Obstructive Pulmonary Disease
Saha, S., Bharshankar, J. R., & Berad, A. (2020) · International Journal of Health and Clinical Research
Makarevich, A. E., & Lemishevskaia, S. S. (2015) · The Practitioner
Оськин, Д. Н., & Kotlyarov, S. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27208993
Liu, S., Lin, D., Yang, X., Zhu, W., Hantian, Z., Yang, Z., Dong, R., & 林益华 (2026) · Environment International · doi:10.1016/j.envint.2026.110564
Zhong, L., 仲昭双, Ma, W., Sun, Z., Xiao, G., Yu, Y., & Cao, C. (2026) · International Journal of COPD · doi:10.2147/copd.s633286
El-fattah, A. Y. A., Abdelwahab, H. W., Rezk, N. A., & El-Morsey, R. A. (2026) · Egyptian Journal of Bronchology · doi:10.1186/s43168-026-00709-x
Qiao, X., Hou, G., Kang, J., Wang, Q.-Y., & Yin, Y. (2022) · doi:10.3389/fphys.2022.833796.s001
Calvert, L. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Pharmacotherapeutic options in sarcoidosis : how can we improve them?
Cremers, J. P. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140626jc
Lima, D. F. (2009) · Americanae (AECID Library)
Early pulmonary rehabilitation for exacerbations of chronic obstructive pulmonary disease
Greening, N. J. (2014) · Figshare
Mesquita, C. B. (2014) · Americanae (AECID Library)
Consumo energetico durante Test del Cammino in pazienti BPCO con Insufficienza Respiratoria Cronica
Crisafulli, E. (2010) · DSpaceUnipr (University of Parma)
Breyer, M. (2013)
Metadata
- Authors
- Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Schols, Annemie MWJ
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 82
- Issue
- 1
- Pages
- 53-59
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2150051820
- Cited by
- 902
- References
- 35
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 34 · 2023: 44 · 2022: 41 · 2021: 47 · 2020: 49 · 2019: 49 · 2018: 45 · 2017: 45 · 2016: 60 · 2015: 57 · 2014: 61 · 2013: 55 · 2012: 37
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6456 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- chronic obstructive pulmonary disease, body composition, mortality, fat-free mass index, fat mass index, skeletal muscle index, cachexia, muscle atrophy, semistarvation, disease severity
- MeSH terms
- Body Composition, Body Weight, Cachexia, Female, Humans, Male, Middle Aged, Reference Values, Respiratory Function Tests, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.